Differences in SPET analysis of thyroid-associated orbitopathy.
Galuska
Lázló
L
Varga
József
J
Szücs-Farkas
Zsolt
Z
Nagy
Endre V
EV
Burman
Kenneth D
KD
D000465:Algorithms; D006111:Graves Disease / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D007090:Image Interpretation, Computer-Assisted / Q000379:methods*; D007765:Lacrimal Apparatus / Q000000981:diagnostic imaging* / Q000378:metabolism; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000378:metabolism; D008279:Magnetic Resonance Imaging / Q000379:methods; D009296:Nasal Cavity / Q000000981:diagnostic imaging / Q000378:metabolism; D009333:Neck; D015282:Octreotide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D009916:Orbital Diseases; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012469:Salivary Glands / Q000000981:diagnostic imaging / Q000378:metabolism; D013382:Subtraction Technique; D014018:Tissue Distribution; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D014057:Tomography, X-Ray Computed / Q000379:methods
D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C410263:technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotide; D015282:Octreotide